{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T05:23:39Z","timestamp":1733289819223,"version":"3.30.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,12,3]]},"DOI":"10.7759\/cureus.75021","type":"journal-article","created":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T12:08:07Z","timestamp":1733227687000},"source":"Crossref","is-referenced-by-count":0,"title":["Cross-Sectional Analyses to Assess the Clinical Safety and Effectiveness of Bisoprolol in Patients With Non-obstructive Coronary Artery Disease Who Underwent Percutaneous Coronary Intervention: A Post-hoc Analysis"],"prefix":"10.7759","author":[{"given":"Brian","family":"Pinto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Girish R","family":"Kulkarni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soumitra","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arup","family":"Deb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louie","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amit","family":"Khandelwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krishnaprasad R","family":"Korukonda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rathish","family":"Nair","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2022.11.005","article-title":"The global burden of cardiovascular diseases and risk: a compass for future health","volume":"80","author":"Vaduganathan M","year":"2022","unstructured":"Vaduganathan M, Mensah GA, Turco JV, Fuster V, Roth GA. The global burden of cardiovascular diseases and risk: a compass for future health. J Am Coll Cardiol. 2022, 80:2361-71. 10.1016\/j.jacc.2022.11.005","journal-title":"J Am Coll Cardiol"},{"key":"ref2","article-title":"Coronary artery disease","author":"Shahjehan RD","year":"2023","unstructured":"Shahjehan RD, Bhutta BS. Coronary artery disease. StatPearls. StatPearls Publishing, Treasure Island; 2023."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.mjafi.2019.12.005","article-title":"Cardiovascular disease in India: a 360 degree overview","volume":"76","author":"Sreeniwas Kumar A","year":"2020","unstructured":"Sreeniwas Kumar A, Sinha N. Cardiovascular disease in India: a 360 degree overview. Med J Armed Forces India. 2020, 76:1-3. 10.1016\/j.mjafi.2019.12.005","journal-title":"Med J Armed Forces India"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12196412","article-title":"Coronary artery disease: a key issue in type 2 myocardial infarction: systematic review and recent findings","volume":"12","author":"Yao H","year":"2023","unstructured":"Yao H, Zeller M, N'Guetta R, Cottin Y, Putot A. Coronary artery disease: a key issue in type 2 myocardial infarction: systematic review and recent findings. J Clin Med. 2023, 12:10.3390\/jcm12196412","journal-title":"J Clin Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000001029","article-title":"2021 AHA\/ACC\/ASE\/CHEST\/SAEM\/SCCT\/SCMR guideline for the evaluation and diagnosis of chest pain: a report of the American College of Cardiology\/American Heart Association Joint Committee on clinical practice guidelines","volume":"144","author":"Gulati M","year":"2021","unstructured":"Gulati M, Levy PD, Mukherjee D, et al.. 2021 AHA\/ACC\/ASE\/CHEST\/SAEM\/SCCT\/SCMR guideline for the evaluation and diagnosis of chest pain: a report of the American College of Cardiology\/American Heart Association Joint Committee on clinical practice guidelines. Circulation. 2021, 144:e368-454. 10.1161\/CIR.0000000000001029","journal-title":"Circulation"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000670","article-title":"Contemporary diagnosis and management of patients with myocardial infarction in the absence of obstructive coronary artery disease: a scientific statement from the American Heart Association","volume":"139","author":"Tamis-Holland JE","year":"2019","unstructured":"Tamis-Holland JE, Jneid H, Reynolds HR, et al.. Contemporary diagnosis and management of patients with myocardial infarction in the absence of obstructive coronary artery disease: a scientific statement from the American Heart Association. Circulation. 2019, 139:e891-908. 10.1161\/CIR.0000000000000670","journal-title":"Circulation"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.0000020805.31531.48","article-title":"Health status and clinical practice: when will they meet?","volume":"106","author":"Rumsfeld JS","year":"2002","unstructured":"Rumsfeld JS. Health status and clinical practice: when will they meet?. Circulation. 2002, 106:5-7. 10.1161\/01.cir.0000020805.31531.48","journal-title":"Circulation"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2014.03.001","article-title":"Prevalence and predictors of nonobstructive coronary artery disease identified with coronary angiography in contemporary clinical practice","volume":"167","author":"Patel MR","year":"2014","unstructured":"Patel MR, Dai D, Hernandez AF, et al.. Prevalence and predictors of nonobstructive coronary artery disease identified with coronary angiography in contemporary clinical practice. Am Heart J. 2014, 167:846-52.e2. 10.1016\/j.ahj.2014.03.001","journal-title":"Am Heart J"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2014.14681","article-title":"Nonobstructive coronary artery disease and risk of myocardial infarction","volume":"312","author":"Maddox TM","year":"2014","unstructured":"Maddox TM, Stanislawski MA, Grunwald GK, et al.. Nonobstructive coronary artery disease and risk of myocardial infarction. JAMA. 2014, 312:1754-63. 10.1001\/jama.2014.14681","journal-title":"JAMA"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehr331","article-title":"Stable angina pectoris with no obstructive coronary artery disease is associated with increased risks of major adverse cardiovascular events","volume":"33","author":"Jespersen L","year":"2012","unstructured":"Jespersen L, Hvelplund A, Abildstr\u00f8m SZ, et al.. Stable angina pectoris with no obstructive coronary artery disease is associated with increased risks of major adverse cardiovascular events. Eur Heart J. 2012, 33:734-44. 10.1093\/eurheartj\/ehr331","journal-title":"Eur Heart J"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1097\/MOL.0b013e3282efa326","article-title":"Molecular mechanisms of plaque instability","volume":"18","author":"Shah PK","year":"2007","unstructured":"Shah PK. Molecular mechanisms of plaque instability. Curr Opin Lipidol. 2007, 18:492-9. 10.1097\/MOL.0b013e3282efa326","journal-title":"Curr Opin Lipidol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.121.023207","article-title":"Prevalence of coronary microvascular disease and coronary vasospasm in patients with nonobstructive coronary artery disease: systematic review and meta-analysis","volume":"11","author":"Mileva N","year":"2022","unstructured":"Mileva N, Nagumo S, Mizukami T, et al.. Prevalence of coronary microvascular disease and coronary vasospasm in patients with nonobstructive coronary artery disease: systematic review and meta-analysis. J Am Heart Assoc. 2022, 11:e023207. 10.1161\/JAHA.121.023207","journal-title":"J Am Heart Assoc"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacasi.2023.01.004","article-title":"Ischemia with nonobstructive coronary artery disease: concept, assessment, and management","volume":"3","author":"Hwang D","year":"2023","unstructured":"Hwang D, Park SH, Koo BK. Ischemia with nonobstructive coronary artery disease: concept, assessment, and management. JACC Asia. 2023, 3:169-84. 10.1016\/j.jacasi.2023.01.004","journal-title":"JACC Asia"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehaa376","article-title":"Long-term \u03b2-blocker therapy and clinical outcomes after acute myocardial infarction in patients without heart failure: nationwide cohort study","volume":"41","author":"Kim J","year":"2020","unstructured":"Kim J, Kang D, Park H, et al.. Long-term \u03b2-blocker therapy and clinical outcomes after acute myocardial infarction in patients without heart failure: nationwide cohort study. Eur Heart J. 2020, 41:3521-9. 10.1093\/eurheartj\/ehaa376","journal-title":"Eur Heart J"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000001168","article-title":"2023 AHA\/ACC\/ACCP\/ASPC\/NLA\/PCNA guideline for the management of patients with chronic coronary disease: a report of the American Heart Association\/American College of Cardiology joint committee on clinical practice guidelines","volume":"148","author":"Virani SS","year":"2023","unstructured":"Virani SS, Newby LK, Arnold SV, et al.. 2023 AHA\/ACC\/ACCP\/ASPC\/NLA\/PCNA guideline for the management of patients with chronic coronary disease: a report of the American Heart Association\/American College of Cardiology joint committee on clinical practice guidelines. Circulation. 2023, 148:e9-e119. 10.1161\/CIR.0000000000001168","journal-title":"Circulation"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s10741-017-9660-1","article-title":"Pharmacological heart rate lowering in patients with a preserved ejection fraction-review of a failing concept","volume":"23","author":"Meyer M","year":"2018","unstructured":"Meyer M, Rambod M, LeWinter M. Pharmacological heart rate lowering in patients with a preserved ejection fraction-review of a failing concept. Heart Fail Rev. 2018, 23:499-506. 10.1007\/s10741-017-9660-1","journal-title":"Heart Fail Rev"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1038\/s41371-021-00494-8","article-title":"Intensive blood pressure treatment in coronary artery disease: implications from the Systolic Blood Pressure Intervention Trial (SPRINT)","volume":"36","author":"Zang J","year":"2022","unstructured":"Zang J, Liang J, Zhuang X, Zhang S, Liao X, Wu G. Intensive blood pressure treatment in coronary artery disease: implications from the Systolic Blood Pressure Intervention Trial (SPRINT). J Hum Hypertens. 2022, 36:86-94. 10.1038\/s41371-021-00494-8","journal-title":"J Hum Hypertens"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.14744\/AnatolJCardiol.2020.13247","article-title":"Resting heart rate and real-life treatment modalities in outpatients with left ventricular systolic dysfunction study: a multicenter, prospective, observational, and national registry","volume":"25","author":"\u00c7avu\u015fo\u011flu Y","year":"2021","unstructured":"\u00c7avu\u015fo\u011flu Y, Kozan \u00d6, Temizhan A, K\u00fc\u00e7\u00fcko\u011flu MS. Resting heart rate and real-life treatment modalities in outpatients with left ventricular systolic dysfunction study: a multicenter, prospective, observational, and national registry. Anatol J Cardiol. 2021, 25:304-12. 10.14744\/AnatolJCardiol.2020.13247","journal-title":"Anatol J Cardiol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1097\/CM9.0000000000000802","article-title":"Resting heart rate control and prognosis in coronary artery disease patients with hypertension previously treated with bisoprolol: a sub-group analysis of the BISO-CAD study","volume":"133","author":"Chen YD","year":"2020","unstructured":"Chen YD, Yang XC, Pham VN, et al.. Resting heart rate control and prognosis in coronary artery disease patients with hypertension previously treated with bisoprolol: a sub-group analysis of the BISO-CAD study. Chin Med J (Engl). 2020, 133:1155-65. 10.1097\/CM9.0000000000000802","journal-title":"Chin Med J (Engl)"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/8.suppl_m.15","article-title":"The single dose pharmacokinetics of bisoprolol (10 mg) in renal insufficiency: the clinical significance of balanced clearance","volume":"8 Suppl M","author":"Payton CD","year":"1987","unstructured":"Payton CD, Fox JG, Pauleau NF, Boulton-Jones JM, Ioannides C, Johnston A, Thomas P. The single dose pharmacokinetics of bisoprolol (10 mg) in renal insufficiency: the clinical significance of balanced clearance. Eur Heart J. 1987, 8 Suppl M:15-22. 10.1093\/eurheartj\/8.suppl_m.15","journal-title":"Eur Heart J"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.109.900191","article-title":"Primary coronary microvascular dysfunction: clinical presentation, pathophysiology, and management","volume":"121","author":"Lanza GA","year":"2010","unstructured":"Lanza GA, Crea F. Primary coronary microvascular dysfunction: clinical presentation, pathophysiology, and management. Circulation. 2010, 121:2317-25. 10.1161\/CIRCULATIONAHA.109.900191","journal-title":"Circulation"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvaa003","article-title":"ESC Working Group on Coronary Pathophysiology and Microcirculation position paper on 'coronary microvascular dysfunction in cardiovascular disease'","volume":"116","author":"Padro T","year":"2020","unstructured":"Padro T, Manfrini O, Bugiardini R, et al.. ESC Working Group on Coronary Pathophysiology and Microcirculation position paper on 'coronary microvascular dysfunction in cardiovascular disease'. Cardiovasc Res. 2020, 116:741-55. 10.1093\/cvr\/cvaa003","journal-title":"Cardiovasc Res"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa043012","article-title":"Heart-rate profile during exercise as a predictor of sudden death","volume":"352","author":"Jouven X","year":"2005","unstructured":"Jouven X, Empana JP, Schwartz PJ, Desnos M, Courbon D, Ducimeti\u00e8re P. Heart-rate profile during exercise as a predictor of sudden death. N Engl J Med. 2005, 352:1951-8. 10.1056\/NEJMoa043012","journal-title":"N Engl J Med"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.29011\/2575-7083.100082","article-title":"To evaluate the \u2018real world\u2019 clinical performance of bisoprolol in post-myocardial infarction with left ventricular dysfunction: tenacity study","volume":"70","author":"Sharma K","year":"2022","unstructured":"Sharma K, Desai H, Sharm N, Laddha M, Hansora K, Vazirani P. To evaluate the \u2018real world\u2019 clinical performance of bisoprolol in post-myocardial infarction with left ventricular dysfunction: tenacity study. J Assoc Phys India. 2022, 70:11-2. 10.29011\/2575-7083.100082","journal-title":"J Assoc Phys India"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.ancard.2004.03.003","article-title":"Effects of bisoprolol in patients with stable congestive heart failure","volume":"53","author":"de Groote P","year":"2004","unstructured":"de Groote P, Delour P, Lamblin N, et al.. Effects of bisoprolol in patients with stable congestive heart failure. Ann Cardiol Angeiol (Paris). 2004, 53:167-70. 10.1016\/j.ancard.2004.03.003","journal-title":"Ann Cardiol Angeiol (Paris)"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)11181-9","article-title":"The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial","volume":"353","year":"1999","unstructured":"The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II). a randomised trial. Lancet. 1999, 353:9-13. 10.1016\/S0140-6736(98)11181-9","journal-title":"Lancet"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1001\/jama.281.20.1927","article-title":"Meta-analysis of trials comparing beta-blockers, calcium antagonists, and nitrates for stable angina","volume":"281","author":"Heidenreich PA","year":"1999","unstructured":"Heidenreich PA, McDonald KM, Hastie T, Fadel B, Hagan V, Lee BK, Hlatky MA. Meta-analysis of trials comparing beta-blockers, calcium antagonists, and nitrates for stable angina. JAMA. 1999, 281:1927-36. 10.1001\/jama.281.20.1927","journal-title":"JAMA"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1258\/smj.2011.011274","article-title":"The impact of beta-blockers on mortality in stable angina: a meta-analysis","volume":"57","author":"Huang HL","year":"2012","unstructured":"Huang HL, Fox KA. The impact of beta-blockers on mortality in stable angina: a meta-analysis. Scott Med J. 2012, 57:69-75. 10.1258\/smj.2011.011274","journal-title":"Scott Med J"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/313902-cross-sectional-analyses-to-assess-the-clinical-safety-and-effectiveness-of-bisoprolol-in-patients-with-non-obstructive-coronary-artery-disease-who-underwent-percutaneous-coronary-intervention-a-post-hoc-analysis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T12:08:09Z","timestamp":1733227689000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/313902-cross-sectional-analyses-to-assess-the-clinical-safety-and-effectiveness-of-bisoprolol-in-patients-with-non-obstructive-coronary-artery-disease-who-underwent-percutaneous-coronary-intervention-a-post-hoc-analysis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,3]]},"references-count":28,"URL":"https:\/\/doi.org\/10.7759\/cureus.75021","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12,3]]}}}